Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 1-25 of 35 citing articles:

Once-Weekly Insulin Icodec vs Once-Daily Insulin Degludec in Adults With Insulin-Naive Type 2 Diabetes
Ildiko Lingvay, Marisse Asong, Cyrus Desouza, et al.
JAMA (2023) Vol. 330, Iss. 3, pp. 228-228
Open Access | Times Cited: 83
The Basis for Weekly Insulin Therapy: Evolving Evidence With Insulin Icodec and Insulin Efsitora Alfa
Julio Rosenstock, Rattan Juneja, John M. Beals, et al.
Endocrine Reviews (2024) Vol. 45, Iss. 3, pp. 379-413
Open Access | Times Cited: 31
Evolving understanding of autoimmune mechanisms and new therapeutic strategies of autoimmune disorders
Yi Song, Jian Li, Yuzhang Wu
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 13
Insulin Efsitora versus Degludec in Type 2 Diabetes without Previous Insulin Treatment
Carol Wysham, Harpreet S. Bajaj, Stefano Del Prato, et al.
New England Journal of Medicine (2024)
Closed Access | Times Cited: 12
Once‐weekly insulin efsitora alfa: Design and rationale for the QWINT phase 3 clinical development programme
Richard M. Bergenstal, Athena Philis‐Tsimikas, Carol Wysham, et al.
Diabetes Obesity and Metabolism (2024) Vol. 26, Iss. 8, pp. 3020-3030
Open Access | Times Cited: 11
Once-weekly insulins: a promising approach to reduce the treatment burden in people with diabetes
Roberto Trevisan, Matteo Conti, Stefano Ciardullo
Diabetologia (2024) Vol. 67, Iss. 8, pp. 1480-1492
Open Access | Times Cited: 10
Pharmacokinetic and Pharmacodynamic Properties of Once-Weekly Insulin Efsitora Alfa in Japanese Patients with Type 2 Diabetes
Risa Nasu, Tomonori Oura, Kenji Ohwaki, et al.
Diabetes Therapy (2025)
Open Access | Times Cited: 1
Pharmacokinetic and pharmacodynamic properties of once‐weekly insulin icodec in individuals with type 2 diabetes
Thomas R. Pieber, Marisse Asong, Gabriele Fluhr, et al.
Diabetes Obesity and Metabolism (2023) Vol. 25, Iss. 12, pp. 3716-3723
Open Access | Times Cited: 19
Current usage of long-acting insulin analogs in patients with type 2 diabetes mellitus
Gülali Aktaş, Tuba Taslamacıoğlu Duman
Expert Review of Endocrinology & Metabolism (2024) Vol. 19, Iss. 2, pp. 155-161
Closed Access | Times Cited: 6
Efficacy and Safety of Once-Weekly Insulin Regimes on Glycemic Control for Type 2 Diabetes: A Systematic Review and Network Meta-analysis
Peng Wang, Yu Zhang, W. Xu, et al.
Diabetology & Metabolic Syndrome (2024) Vol. 16, Iss. 1
Open Access | Times Cited: 5
Research Advances in Fusion Protein-Based Drugs for Diabetes Treatment
Wen-Ying Deng, Z Zhao, Tao Zou, et al.
Diabetes Metabolic Syndrome and Obesity (2024) Vol. Volume 17, pp. 343-362
Open Access | Times Cited: 4
Understanding the Pharmacokinetics and Glucodynamics of Once Weekly Basal Insulins to Inform Dosing Principles: An Introduction to Clinicians
Thomas R. Pieber, Jennifer Leohr, Juliana Bue‐Valleskey, et al.
Endocrine Practice (2024) Vol. 30, Iss. 9, pp. 863-869
Open Access | Times Cited: 4
Efficacy and safety of once‐weekly versus once‐daily basal insulin analogues in the treatment of type 2 diabetes mellitus: A systematic review and meta‐analysis
Paschalis Karakasis, Dimitrios Patoulias, Konstantinos Pamporis, et al.
Diabetes Obesity and Metabolism (2023) Vol. 25, Iss. 12, pp. 3648-3661
Closed Access | Times Cited: 10
The rise of weekly insulins: addressing the challenges of type 2 diabetes care in Brazil
André Gustavo Daher Vianna, Diana Alves, Taís Silveira Assmann, et al.
Diabetology & Metabolic Syndrome (2025) Vol. 17, Iss. 1
Open Access
Once-weekly Basal Insulin Fc versus daily insulin degludec for glycemic control in diabetes: a systematic review, meta-analysis, and meta-regression
Sandesh Raja, Adarsh Raja, Azzam Ali, et al.
Journal of Diabetes & Metabolic Disorders (2025) Vol. 24, Iss. 1
Closed Access
HbA1c reduction strategies: An overview of pharmacological interventions
Krishna Upadhye, Hariom Patidar, Narendra Bamnia, et al.
National Journal of Pharmacology and Therapeutics (2025) Vol. 3, Iss. 1, pp. 24-33
Closed Access
Once Weekly Insulin: The Battle of 52 versus 365
J Thomas, Nidhi Mathews
Open Journal of Internal Medicine (2025) Vol. 15, Iss. 02, pp. 97-106
Open Access
Comparative efficacy and safety of weekly tirzepatide versus weekly insulin in type 2 diabetes: A network meta‐analysis of randomized clinical trials
Hazem Ayesh, Sajida Suhail, Suhail Ayesh, et al.
Diabetes Obesity and Metabolism (2024) Vol. 26, Iss. 9, pp. 3801-3809
Open Access | Times Cited: 2
Frequency and Severity of Hypoglycemia Under Conditions of Increased Hypoglycemic Risk with Insulin Efsitora Alfa Versus Insulin Glargine Treatment in Participants with Type 2 Diabetes
Tim Heise, Grit Andersen, Edward Pratt, et al.
Diabetes Therapy (2024) Vol. 15, Iss. 8, pp. 1785-1797
Open Access | Times Cited: 2
Once-Weekly Insulin Icodec in Diabetes Mellitus: A Systematic Review and Meta-Analysis of Randomized Clinical Trials (ONWARDS Clinical Program)
Giuseppe Lisco, Anna De Tullio, Vincenzo De Geronimo, et al.
Biomedicines (2024) Vol. 12, Iss. 8, pp. 1852-1852
Open Access | Times Cited: 2
Novel Agents in the Management of Diabetes and Risk of Worsening Diabetic Retinopathy
Rithwick Rajagopal, Janet B. McGill
Retina (2024) Vol. 44, Iss. 11, pp. 1851-1859
Closed Access | Times Cited: 2
The 2022 American Diabetes Association Meeting
Zachary T. Bloomgarden
Journal of Diabetes (2022) Vol. 14, Iss. 7, pp. 428-433
Open Access | Times Cited: 8
Current Status of Weekly Insulin Analogs and Their Pharmacokinetic/Pharmacodynamic Evaluation by the Euglycemic Clamp Technique
Na An, Xuhong Wang, Anshun He, et al.
Clinical Pharmacology in Drug Development (2023) Vol. 12, Iss. 9, pp. 849-855
Closed Access | Times Cited: 4
A diabetes update
Zachary T. Bloomgarden
Journal of Diabetes (2023) Vol. 15, Iss. 7, pp. 542-544
Open Access | Times Cited: 4
Clinical perspectives on the frequency of hypoglycemia in treat-to-target randomized controlled trials comparing basal insulin analogs in type 2 diabetes: a narrative review
Julio Rosenstock, Harpreet S. Bajaj, Ildiko Lingvay, et al.
BMJ Open Diabetes Research & Care (2024) Vol. 12, Iss. 3, pp. e003930-e003930
Open Access | Times Cited: 1
Page 1 - Next Page

Scroll to top